Silencing SAPCD2 Represses Proliferation and Lung Metastasis of Fibrosarcoma by Activating Hippo Signaling Pathway.
Silencing SAPCD2 Represses Proliferation and Lung Metastasis of Fibrosarcoma by Activating Hippo Signaling Pathway.
复制标题
通过激活 Hippo 信号通路沉默 SAPCD2 抑制纤维肉瘤的增殖和肺转移
DOI:
10.3389/fonc.2020.574383
复制
发表时间:
2020
影响因子:
4.7
通讯作者:
Fan W
中科院分区:
文献类型:
--
作者:
Zhu B;Wu Y;Niu L;Yao W;Xue M;Wang H;Yang J;Li J;Fan W
The primary problem associated with fibrosarcoma is its high potential to metastasize to the lung. Aberrant expression of SAPCD2 has been widely reported to be implicated in the progression and metastasis in multiple cancer types. However, the clinical significance and biological roles of SAPCD2 in fibrosarcoma remain unknown. Here, we reported that SAPCD2 expression was markedly elevated in fibrosarcoma tissues, and its expression was differentially upregulated in fibrosarcoma cell lines compared with that in several primary fibroblast cell lines. Kaplan-Meier survival analysis revealed that SAPCD2 overexpression was significantly correlated with early progression and metastasis, and poor prognosis in fibrosarcoma patients. Our results further showed that silencing SAPCD2 inhibited the proliferation and increased the apoptosis of fibrosarcoma cells in vitro. Importantly, silencing SAPCD2 repressed lung metastasis of fibrosarcoma cells in vivo. Mechanistic investigation further demonstrated that silencing SAPCD2 inhibited the proliferation and lung metastasis of fibrosarcoma cells by activating the Hippo signaling pathway, as evidenced by the finding that constitutively active YAP1, YAP1-S127A, significantly reversed the inhibitory effect of SAPCD2 downregulation on the colony formation and anchorage-independent growth capabilities of fibrosarcoma cells, as well as the stimulatory effect on the apoptotic ratio of fibrosarcoma cells. In conclusion, SAPCD2 promotes the proliferation and lung metastasis of fibrosarcoma cells by regulating the activity of Hippo signaling, and this mechanism represents a potential therapeutic target for the treatment of lung metastatic fibrosarcoma.
登录
查看更多内容
影响因子:
9.7
作者:
Chen, Jiarong;Liu, Aibin;Huang, Yanming
通讯作者:
Huang, Yanming
影响因子:
--
作者:
Augsburger D;Nelson PJ;Kalinski T;Udelnow A;Knösel T;Hofstetter M;Qin JW;Wang Y;Gupta AS;Bonifatius S;Li M;Bruns CJ;Zhao Y
通讯作者:
Zhao Y
影响因子:
4.4
作者:
Kim, Yong-In;Lee, Jongan;Cho, Je-Yoel
通讯作者:
Cho, Je-Yoel
影响因子:
3.5
作者:
Miller, Nimrod;Shi, Han;Ma, Yong-Chao
通讯作者:
Ma, Yong-Chao
影响因子:
8.8
作者:
Dai, Yuhu;Ren, Dong;Peng, Xinsheng
通讯作者:
Peng, Xinsheng